Parmantier sets EUR 20.50 target for Evonik stock

Published on 10/13/2026 at 14:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik reports on November 3, 2026. Evonik stock costs EUR 21.23 on October 13, 2026 at 2:13 p.m. CEST, up 0.62 percent versus the Xetra close.

Array

Geometrisches Bauhaus-Poster mit fettem Text CHEMIE in Primärfarben Rot Gelb Blau nach 1920er Stil — Evonik Industries DE000EVNK013 als geometrisches Bauhaus-Poster mit dem Sektor-Text CHEMIE in leuchtenden Primärfarben, Illustration mit AI erstellt.

Parmantier & Cie. set a Hold rating and a EUR 20.50 12-month target for Evonik on October 6, 2026, according to EQS News. With Evonik stock at EUR 21.23, the target is 3.44 percent below the price. At Lang & Schwarz, the stock was trading at EUR 21.23 on October 13, 2026 at 2:13 p.m. CEST, up 0.62 percent versus the Xetra close of October 12, 2026 at EUR 21.10.

Second-quarter earnings stay elevated

Evonik's adjusted EBITDA rose 24.00 percent year over year to EUR 630.0 million in the second quarter of 2026, according to the company's earnings call transcript carried by Yahoo Finance on August 4, 2026. Management said the result benefited from higher volumes and prices, while the call also described temporary supply-chain support and continuing structural challenges.

Stock sits near its yearly high

The EUR 21.23 Lang & Schwarz price is 1.89 percent below the EUR 21.64 52-week high and well above the EUR 12.49 low, based on the October 13, 2026 quote. Market capitalization stood at EUR 9.9 billion, the price-to-earnings ratio was 82.13 and the trailing dividend yield was 0.05 percent on the same date. Trading volume was 151,617 shares against an average of 1,322,737.

Results date gives the next test

Evonik's investor-relations calendar schedules its third-quarter 2026 report for November 3, 2026, while its 2027 full-year report is scheduled for March 4, 2027, according to Evonik. For the stock, the gap between the current quote and the October 6 target places more weight on the upcoming results than on the rating label alone.

Comparison with peers

Evonik (Xetra, EUR): plus 0.62 percent, P/E 82.13, market capitalization EUR 9.9 billion

BASF (Xetra, EUR): minus 0.18 percent, P/E 7.70, market capitalization EUR 44.1 billion

Wacker Chemie (Xetra, EUR): plus 0.17 percent, P/E minus 9.89, market capitalization EUR 4.3 billion

Price remains close to the high

Evonik stock was trading at EUR 21.23 at Lang & Schwarz on October 13, 2026 at 2:13 p.m. CEST, up 0.62 percent versus the Xetra close of October 12, 2026 at EUR 21.10. The further course of trading is shown by the continuously updated real-time quote of Evonik stock.